back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-04 14:40 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+500,000 vol |
500,000 | |
| Filed 2025-07-02 16:24 Tx date 2025-04-08 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80.00
-500 vol $0.16 each |
39,722 | |
| Filed 2025-07-02 16:23 Tx date 2025-04-08 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,800
-32,000 vol $0.15 each |
40,222 | |
| Filed 2025-03-20 18:20 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,166
+72,222 vol $0.21 each |
72,222 | |
| Filed 2025-03-20 18:19 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-38,889 vol |
0 | |
| Filed 2025-03-20 18:19 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-72,222 vol |
38,889 | |
| Filed 2025-01-20 12:32 Tx date 2025-01-10 |
$TGGL
Toggle3D.ai Inc. |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,750
+50,000 vol $0.095 each |
50,000 | |
| Filed 2025-01-20 12:31 Tx date 2024-12-09 |
$TGGL
Toggle3D.ai Inc. |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-01-20 12:30 Tx date 2025-01-10 |
$NTAR
NexTech3D.ai Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,500
+50,000 vol $0.07 each |
50,000 | |
| Filed 2025-01-20 12:29 Tx date 2024-12-09 |
$NTAR
NexTech3D.ai Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-01-20 12:29 Tx date 2025-01-10 |
$ARWY
Arway Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,750
+50,000 vol $0.055 each |
50,000 | |
| Filed 2025-01-20 12:20 Tx date 2024-12-09 |
$ARWY
Arway Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-01 12:05 Tx date 2024-11-01 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,348.84
-65,222 vol $0.22 each |
0 | |
| Filed 2024-11-01 12:05 Tx date 2024-11-01 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-230.00
-1,000 vol $0.23 each |
65,222 | |
| Filed 2024-11-01 12:05 Tx date 2024-10-31 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-115.00
-500 vol $0.23 each |
66,222 | |
| Filed 2024-11-01 12:04 Tx date 2024-10-30 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,265
-5,500 vol $0.23 each |
66,722 | |
| Filed 2024-09-23 16:03 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$17,333
+72,222 vol $0.24 each |
72,222 | |
| Filed 2024-09-23 16:03 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-38,889 vol |
111,111 | |
| Filed 2024-09-23 16:02 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-72,222 vol |
150,000 | |
| Filed 2024-09-23 15:59 Tx date 2024-09-06 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,333.28
-72,222 vol $0.24 each |
0 | |
| Filed 2024-09-23 14:09 Tx date 2024-09-06 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
10 - Acquisition or disposition in the public market
|
-72,222 vol |
||
| Filed 2024-09-12 07:35 Tx date 2024-09-06 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
10 - Acquisition or disposition in the public market
|
-72,222 vol |
||
| Filed 2024-09-12 07:35 Tx date 2024-09-06 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
10 - Acquisition or disposition in the public market
|
-72,222 vol |
150,000 | |
| Filed 2024-03-28 10:49 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+72,222 vol |
72,222 | |
| Filed 2024-03-28 10:49 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:49 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-38,889 vol |
222,222 | |
| Filed 2024-03-28 10:48 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-72,222 vol |
261,111 | |
| Filed 2024-03-18 11:52 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+333,333 vol |
333,333 | |
| Filed 2024-03-18 11:51 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-15 15:06 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
775,000 | |
| Filed 2021-09-09 14:43 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
550,000 | |
| Filed 2020-04-30 20:51 Tx date 2020-04-19 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2020-04-30 15:56 Tx date 2020-01-22 |
$INNO
InnoCan Pharma Corporation |
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|